» Authors » C Hosing

C Hosing

Explore the profile of C Hosing including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 807
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Srour S, Singh H, McCarty J, de Groot E, Huls H, Rondon G, et al.
Blood . 2020 Jan; 135(11):862-865. PMID: 31961918
No abstract available.
2.
Jain P, Aoki E, Keating M, Wierda W, OBrien S, Gonzalez G, et al.
Ann Oncol . 2017 Apr; 28(7):1554-1559. PMID: 28379307
Background: T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive disease. In this study, we report our experience from 119 patients with T-PLL. Patients And Methods: We reviewed the clinico-pathologic...
3.
Brammer J, Saliba R, Jorgensen J, Ledesma C, Gaballa S, Poon M, et al.
Bone Marrow Transplant . 2016 Sep; 52(1):20-27. PMID: 27618682
This study aims to provide a detailed analysis of allogeneic stem cell transplantation (allo-SCT) outcomes in a large T-cell acute lymphoblastic leukemia (T-ALL) cohort with a specific emphasis on the...
4.
Varma A, Saliba R, Torres H, Afrough A, Hosing C, Khouri I, et al.
Bone Marrow Transplant . 2016 Mar; 51(7):999-1001. PMID: 26950376
No abstract available.
5.
Cornelison A, Saliba R, Afrough A, Dinh Y, Nieto Y, Bashir Q, et al.
Bone Marrow Transplant . 2015 Oct; 51(2):307-9. PMID: 26479980
No abstract available.
6.
Valdez B, Brammer J, Li Y, Murray D, Liu Y, Hosing C, et al.
Blood Cancer J . 2015 Oct; 5:e357. PMID: 26473529
Romidepsin is a cyclic molecule that inhibits histone deacetylases. It is Food and Drug Administration-approved for treatment of cutaneous and peripheral T-cell lymphoma, but its precise mechanism of action against...
7.
Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, Ciurea S, et al.
Ann Oncol . 2015 Sep; 26(12):2490-5. PMID: 26416896
Background: Cutaneous T-cell lymphomas (CTCLs) and its common variants mycosis fungoides (MF) and leukemic Sézary syndrome (SS) are rare extranodal non-Hodgkin's lymphomas. Patients who present with advanced disease and large-cell...
8.
Parmar S, de Lima M, Worth L, Petropoulos D, Lee D, Cooper L, et al.
Bone Marrow Transplant . 2014 May; 49(8):1109-12. PMID: 24797184
No abstract available.
9.
Wang M, Fowler N, Wagner-Bartak N, Feng L, Romaguera J, Neelapu S, et al.
Leukemia . 2013 Apr; 27(9):1902-9. PMID: 23545991
Lenalidomide-rituximab therapy is effective in grade 1-2 follicular and mantle cell lymphoma, but its efficacy in diffuse large B-cell lymphoma (DLBCL), transformed large cell lymphoma (TL) and grade 3 follicular...
10.
Poon L, Bassett Jr R, Rondon G, Hamdi A, Qazilbash M, Hosing C, et al.
Bone Marrow Transplant . 2012 Oct; 48(5):666-70. PMID: 23085830
For patients with ALL who relapse following allo-SCT, only a second SCT provides a realistic chance for long-term disease remission. We retrospectively analyzed the outcomes of 31 patients with relapsed...